LONDON (Reuters) – Britain is starting to plan for a COVID-19 vaccine booster campaign starting later this year after top vaccine advisers said it might be necessary to give third shots to the elderly and most vulnerable from September. The government said that a final decision on whether a vaccine […]
Read More
JERUSALEM (Reuters) – The Pfizer-BioNTech vaccine is highly effective against the Delta variant of COVID-19, a Pfizer official in Israel said on Thursday. First identified in India, Delta is becoming the globally dominant version of the coronavirus, according to the World Health Organization. “The data we have today, accumulating from […]
Read More
The U.S. will narrowly miss President Joe Biden’s goal of having 70% of the country’s adults at least partially vaccinated by July 4 — a result of lagging vaccination rates among 18- to 26-year-olds, White House officials said Tuesday. “The reality is, many younger Americans have felt like COVID-19 is […]
Read More
The first cases of large vessel arterial occlusion strokes linked to the AstraZeneca COVID-19 vaccine have been described in the United Kingdom. The three cases (one of which was fatal) occurred in two women and one man in their 30s or 40s and involved blockages of the carotid and middle […]
Read More
June 4, 2021 — The Pfizer COVID-19 vaccine produces lower levels of antibodies against the Delta variant, known as B.1.617.2 and discovered in India, according to a new study published Thursday in The Lancet. The antibody levels also appear to be lower in older people and decline over time, which could mean that […]
Read More
As we continue to fight the COVID-19 pandemic at home and work to end the pandemic worldwide, President Biden has promised that the United States will be an arsenal of vaccines for the world. To do that, the Administration will pursue several additional measures beyond our robust funding for COVAX: […]
Read More
The final week of February 2021 set two contrasting milestones in the COVID-19 pandemic. The week began mourning the more than 500,000 lives lost in this country so far in the pandemic. It ended with hope: a third COVID-19 vaccine, using a new technology platform. Introducing Janssen’s new viral vector vaccine, awarded the […]
Read More
A new study that systematically monitored rates of vascular and thromboembolic events in people receiving the AstraZeneca COVID-19 vaccine has found it to be associated with a rate of cerebral venous sinus thrombosis (CVST) of 1 in 40,000. Using national health records, the researchers identified rates of arterial and venous […]
Read More
Scientists told Salon what you need to know about mixing different COVID-19 vaccines In mid-April, the New York Post ran a story about a worried patient who suffered a vaccine mix-up. “Man accidentally gets one Moderna and one Pfizer COVID vaccine,” the headline read. Both the Moderna and the Pfizer coronavirus vaccines, […]
Read More
The messenger RNA vaccine BNT162b2 (Pfizer–BioNTech) has 95% efficacy against coronavirus disease 2019 (Covid-19).1 Qatar launched a mass immunization campaign with this vaccine on December 21, 2020. As of March 31, 2021, a total of 385,853 persons had received at least one vaccine dose and 265,410 had completed the two doses. […]
Read More